News

Supported by XLerateHealth, a health care startup accelerator in Louisville, Kentucky, and by UK, EnRICH is an outgrowth of NIH funding UK received in October 2018 — $3.5 million over three years — to create the XLerator Network.

The National Institutes of Health award will fund ongoing research led by UK Neuroscience and Spinal Cord and Brain Injury Research Center (SCoBIRC) Professor Patrick Sullivan, Ph.D., who has studied the effects of the experimental drug MP201 on TBI.

This work is looking at a study medication, BAN2401, to determine if it can help prevent worsening memory and thinking among individuals who might be at risk for future decline. They are hoping it will ultimately help prevent Alzheimer’s disease.

The five-year reaccreditation process involved an AAHRPP application consisting of some 1,700 pages, completed by ORI staff, describing the HRPP at UK and culminated with a two-day site visit.

“In our study, Polistes dominula was the most common wasp seen hunting caterpillars in Central Kentucky gardens. We think it may be a game-changer for urban monarch conservation."

Under the enhanced UKAccel, the Launch Blue team will provide professional development and experiential learning to UK innovators who are interested in learning the best commercialization path for their technology.

A group led by the Markey Cancer Center researcher Qing-Bai She discovered that SMS is overexpressed in colorectal cancers and plays an important role in balancing cellular spermidine levels that are a necessary adaptation for colorectal cancer growth.

Haupt is one of 35 recipients of the 2020 fellowship, selected from a pool of 429 applicants. He will receive $27,500 for a period of up to two years to complete his dissertation and attend professional development.

The $125,000 grant comes from The CART Fund. CART (Coins for Alzheimer’s Research Trust) is a grassroots effort by Rotary Club members throughout the country to provide cutting edge research to help find a cure for Alzheimer’s.

CCTS is partnering with NCATS, the National Center for Data to Health, and around 60 other clinical institutions affiliated with the NCATS Clinical and Translational Science Awards Program to leverage big data in the fight against COVID-19.